0001193125-24-025896.txt : 20240311 0001193125-24-025896.hdr.sgml : 20240311 20240207063056 ACCESSION NUMBER: 0001193125-24-025896 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CalciMedica, Inc. CENTRAL INDEX KEY: 0001534133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452120079 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-952-5500 MAIL ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: CalciMedica, Inc. /DE/ DATE OF NAME CHANGE: 20230322 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG VISION, INC. DATE OF NAME CHANGE: 20170717 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG, Inc. DATE OF NAME CHANGE: 20150303 CORRESP 1 filename1.htm CORRESP

CALCIMEDICA, INC.

505 Coast Boulevard South, Suite 307

La Jolla, CA 92037

February 7, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Mr. Tyler Howes

 

RE:

CalciMedica, Inc.

Registration Statement on Form S-3

File No. 333-276793

Ladies and Gentlemen:

CalciMedica, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on February 9, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP and Brittany Wightman of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at (858) 550-6157, or in his absence, Brittany Wightman of Cooley LLP at (858) 550-6132.

Very truly yours,

CALCIMEDICA, INC.

 

By:   /s/ A. Rachel Leheny
Name:   A. Rachel Leheny, Ph.D.
Title:   Chief Executive Officer

 

cc:

John Dunn, CalciMedica, Inc.

 

Carlos Ramirez, Cooley LLP

 

Brittany Wightman, Cooley LLP